Geode Capital Management’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.9K Buy
+9,901
New +$40.9K ﹤0.01% 4271
2026
Q2
– Sell
-7,032
Closed -$51.8K – 4458
2026
Q1
$51.8K Buy
7,032
+6,391
+997% +$63.2K ﹤0.01% 4306
2025
Q4
$6.84K Buy
+641
New +$16.8K ﹤0.01% 4447
2024
Q4
– Sell
-25
Closed -$2.56K – 4477
2024
Q3
$2.56K Buy
+25
New +$7.16K ﹤0.01% 4528
2023
Q3
– Hold
0
– -$7.86K – 4768
2023
Q2
– Hold
0
– – – 4728
2023
Q1
– Hold
0
– – – 4758
2022
Q4
– Hold
0
– – – 4838
2022
Q3
– Hold
0
– – – 4893
2022
Q2
– Hold
0
– – – 4970

Other funds holding BJDX

Geode Capital Management's BJDX Position: Q3 2026 in Review

Geode Capital Management opened a new position in Bluejay Diagnostics (BJDX) in Q3 2026: 9,901 shares worth $33.9K. The stake represents ﹤0.01% of the portfolio and ranks #4271 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in BJDX as recently as Q1 2026.

Geode Capital Management first reported a position in BJDX in Q3 2024 and has held it in 4 quarters since. The position peaked at $51.8K in Q1 2026. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.

  • Geode Capital Management held 9,901 shares of Bluejay Diagnostics worth $33.9K as of Q3 2026.
  • Bluejay Diagnostics was a new Geode Capital Management position in Q3 2026.
  • Bluejay Diagnostics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4271 holding.
  • Geode Capital Management first reported a position in Bluejay Diagnostics in Q3 2024 and has held it in 4 quarters since.
  • Geode Capital Management's Bluejay Diagnostics position peaked at $51.8K in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.